Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DELAT PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionNwam Llc
Latest Disclosed Ownership3,519 shares
Latest Disclosed Value $ 537,527
Nwam Llc reports 9.12% increase in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On May 4, 2026 - Nwam Llc filed a 13F-HR form disclosing ownership of 3,519 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $452,192 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 3,225 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 9.12% during the quarter. The current value of the position is $425,799 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,519 294 9.12 538 14.26 0.0309
2026-02-04 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,225 -177 -5.20 471 5.62 0.0263
2026-02-04 2025-09-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,402 -130 -3.68 445 9.07 0.0242
2026-02-04 2025-06-30 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 3,532 3,532 408 0.0237
2025-05-05 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 0 -4,255 -100.00 0 -100.00
2025-02-05 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 4,255 186 4.57 414 -11.54 0.0256
2024-11-12 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,069 4,069 468 0.0285
2024-07-24 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -3,605 -100.00 0 -100.00
2024-05-09 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,605 -645 -15.18 356 -15.64 0.0288
2024-02-14 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 4,250 54 1.29 422 -1.17 0.0339
2023-11-01 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 4,196 -375 -8.20 427 -7.38 0.0434
2023-08-10 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,571 680 17.48 461 29.13 0.0379
2023-05-12 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,891 -571 -12.80 358 -11.63 0.0363
2023-02-08 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 4,462 847 23.43 405 46.91 0.0359
2022-11-14 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 3,615 -1,152 -24.17 275 -31.59 0.0262
2022-08-10 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 4,767 1,351 39.55 402 34.00 0.0371
2022-05-12 2022-03-31 13F NOVARTIS SPONSORED ADR 66987V109 3,416 66 1.97 300 2.39 0.0230
2022-02-10 2021-12-31 13F NOVARTIS SPONSORED ADR 66987V109 3,350 804 31.58 293 40.87 0.0232
2021-11-03 2021-09-30 13F NOVARTIS SPONSORED ADR 66987V109 2,546 -221 -7.99 208 -17.46 0.0189
2021-08-04 2021-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,767 -15 -0.54 252 5.88 0.0234
2021-04-23 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 2,782 27 0.98 238 -8.46 0.0237
2021-01-22 2020-12-31 13F NOVARTIS SPONSORED ADR 66987V109 2,755 2,755 260 0.0297
2020-10-16 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 0 -2,763 -100.00 0 -100.00
2020-07-21 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 2,763 181 7.01 241 13.15 0.0337
2020-04-16 2020-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 2,582 -939 -26.67 213 -36.04 0.0058
2020-01-23 2019-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,521 -380 -9.74 333 -1.77 0.0576
2019-10-15 2019-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,901 661 20.40 339 14.53 0.0634
2019-07-18 2019-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,240 -383 -10.57 296 -14.94 0.0589
2019-04-17 2019-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,623 437 13.72 348 27.47 0.0751
2019-01-30 2018-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,186 -44 -1.36 273 -1.80 0.0701
2018-10-09 2018-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,230 -115 -3.44 278 9.88 0.0625
2018-07-25 2018-06-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 3,345 -19 -0.56 253 -6.99 0.0599
2018-07-16 2018-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,345 -19 253 0.0207
2018-04-16 2018-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,364 -4 -0.12 272 -3.89 0.0687
2018-02-07 2017-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,368 -1,095 -24.54 283 -26.11 0.0717
2017-11-01 2017-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 4,463 614 15.95 383 19.31 0.0996
2017-07-27 2017-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,849 -1,155 -23.08 321 -13.71 0.0558
2017-05-01 2017-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 5,004 1,300 35.10 372 37.78 0.1135
2017-02-02 2016-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 3,704 130 3.64 270 -4.26 0.0896
2016-10-26 2016-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 3,574 3,574 282 0.0214
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.